Press Room

8th Annual Drug Delivery and Formulation Summit

Start
Monday, March 27, 2017 - 09:00
End
Wednesday, March 29, 2017 - 17:00
Location: Berlin, Germany
Booth Number: 4
Spray Drying Contract Manufacturing Hovione Cork | Hovione

Hovione will be attending DFF Summit in Berlin as an official Partner.

Schedule meeting - 8th Annual Drug Delivery and Formulation Summit | Hovione

 

HOVIONE TABLE: #15

 

HOVIONE PRESENTATION
March 27, 2017
14:25 - 15:00
Room 3

On the day 1 of the conference, Hovione will have a slot under the Technology Spotlight. João Henriques (R&D Team Leader) will be presenting on Formulating Amorphous Solid Dispersions: Bridging Particle Engineering and Formulation. This presentation will focus on three main topics:

  1. Critical aspects in the downstream processing of amorphous solid dispersions
  2. Impact of spray dried material properties in final dosage forms production and performance
  3. Optimisation strategies for downstream processing of amorphous solid dispersions

 

If you would like to find more about Hovione's full range of inhalation development services, particle engineering and development by design schedule a meeting with us

Our colleague, Marcel Hogerheide will be pleased to meet you.

Marcel Hogerheide  | Hovione

Marcel Hogerheide

Head of Account Management & Business Development

 

 

DDF Summit Agenda

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025